Investing.com
Published Apr 09, 2024 20:54
Royal Biotek Enhances Everglade Line with New Products
Under this enhanced partnership, Royal Biotek will provide Surge Distribution with 4,000 packages of THCA Flower twice each quarter, generating a consistent revenue stream with each order valued at approximately
The expansion reflects Royal Biotek's unwavering commitment to excellence, quality, and integrity within the cannabis industry. Every product within the Surge Everglade line is meticulously crafted using only the finest ingredients and cutting-edge manufacturing techniques to ensure unmatched potency, purity, and consistency.
"The addition of new products to the Everglade line is a pivotal moment for Royal Biotek, reinforcing our leadership in the fast-evolving cannabis and white label markets," Oswald added. "Our dedication to innovation, customer satisfaction, and regulatory compliance continues to set the standards of excellence in the industry."
In addition to expanding the Everglade line, Royal Biotek is excited to announce an upcoming collaboration with a well-known celebrity tattoo artist. This partnership aims to create a new, all-natural tattoo aftercare product. This move is also expected to significantly increase media exposure. Further details will be shared upon finalizing the contracts.
Branded Legacy also announced the signing of three white label agreements with Surge Distribution Company and Kava & Hobbs just last quarter. These new deals increased revenue from quarter one by over
About Royal Biotek
Royal Biotek, a subsidiary of Branded Legacy, Inc., is at the forefront of developing innovative cannabis solutions. With a focus on quality and customer-centric products, Royal Biotek continues to lead the market in creating unique cannabis experiences for its diverse customer base.
For more information about Royal Biotek and to explore their white label capabilities please visit: https://royalbiotek.com/white-label-program/
Original Copy of this Press Release: https://brandedlegacy.com/branded-legacy-inc-to-add-320000-in-revenue-with-white-label-contract/
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.